X

Trial Profile

The MenQuadfi Pregnancy Registry: A Surveillance Registry to Assess the Safety of MenQuadfi Among Exposed Pregnant Women and Their Offspring

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 06 Nov 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
Indications Meningococcal group A infections; Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal group Y infections
Focus Adverse reactions
Sponsors Sanofi; Sanofi Pasteur

Most Recent Events

30 Jan 2023 Planned End Date changed from 26 Apr 2029 to 18 May 2028.
30 Jan 2023 Planned primary completion date changed from 26 Apr 2029 to 18 May 2028.
03 Jan 2023 Planned End Date changed from 1 May 2028 to 26 Apr 2029.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com